AbbVie's Parkinson's drug Duopa OK'd in US
This article was originally published in Scrip
Executive Summary
AbbVie disclosed on 12 January the FDA had approved Duopa, an enteral suspension formulation of carbidopa and levodopa, as a treatment for motor fluctuations in patients with advanced Parkinson's disease.